These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23776156)

  • 1. The RNase II/RNB family of exoribonucleases: putting the 'Dis' in disease.
    Reis FP; Pobre V; Silva IJ; Malecki M; Arraiano CM
    Wiley Interdiscip Rev RNA; 2013; 4(5):607-15. PubMed ID: 23776156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Implication of mRNA Degradation Disorders on Human DISease: Focus on DIS3 and DIS3-Like Enzymes.
    Saramago M; da Costa PJ; Viegas SC; Arraiano CM
    Adv Exp Med Biol; 2019; 1157():85-98. PubMed ID: 31342438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rrp6 C-terminal domain binds RNA and activates the nuclear RNA exosome.
    Wasmuth EV; Lima CD
    Nucleic Acids Res; 2017 Jan; 45(2):846-860. PubMed ID: 27899565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unravelling the dynamics of RNA degradation by ribonuclease II and its RNA-bound complex.
    Frazão C; McVey CE; Amblar M; Barbas A; Vonrhein C; Arraiano CM; Carrondo MA
    Nature; 2006 Sep; 443(7107):110-4. PubMed ID: 16957732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNase R mutants elucidate the catalysis of structured RNA: RNA-binding domains select the RNAs targeted for degradation.
    Matos RG; Barbas A; Arraiano CM
    Biochem J; 2009 Sep; 423(2):291-301. PubMed ID: 19630750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNase II: the finer details of the Modus operandi of a molecular killer.
    Arraiano CM; Matos RG; Barbas A
    RNA Biol; 2010; 7(3):276-81. PubMed ID: 20484980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of temperature-sensitive mutations and characterization of thermolabile RNase II variants.
    Reis FP; Bárria C; Gomez-Puertas P; Gomes CM; Arraiano CM
    FEBS Lett; 2019 Feb; 593(3):352-360. PubMed ID: 30536706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swapping the domains of exoribonucleases RNase II and RNase R: conferring upon RNase II the ability to degrade ds RNA.
    Matos RG; Barbas A; Gómez-Puertas P; Arraiano CM
    Proteins; 2011 Jun; 79(6):1853-67. PubMed ID: 21465561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the mechanism of RNA degradation by ribonuclease II: identification of the residue responsible for setting the RNase II end product.
    Barbas A; Matos RG; Amblar M; López-Viñas E; Gomez-Puertas P; Arraiano CM
    J Biol Chem; 2008 May; 283(19):13070-6. PubMed ID: 18337246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of 01/A'-A0 pre-rRNA processing by-product in human cells involves cooperative action of two nuclear exosome-associated nucleases: RRP6 and DIS3.
    Kobyłecki K; Drążkowska K; Kuliński TM; Dziembowski A; Tomecki R
    RNA; 2018 Dec; 24(12):1677-1692. PubMed ID: 30266864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How hydrolytic exoribonucleases impact human disease: Two sides of the same story.
    Costa SM; Saramago M; Matos RG; Arraiano CM; Viegas SC
    FEBS Open Bio; 2023 Jun; 13(6):957-974. PubMed ID: 35247037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The eukaryotic RNA exosome.
    Januszyk K; Lima CD
    Curr Opin Struct Biol; 2014 Feb; 24():132-40. PubMed ID: 24525139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Depletion of DIS3, EXOSC10, or XRN2 Reveals the Immediate Impact of Exoribonucleolysis on Nuclear RNA Metabolism and Transcriptional Control.
    Davidson L; Francis L; Cordiner RA; Eaton JD; Estell C; Macias S; Cáceres JF; West S
    Cell Rep; 2019 Mar; 26(10):2779-2791.e5. PubMed ID: 30840897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-regulatory exosome complex confers cellular survival to promote erythropoiesis.
    Mehta C; Fraga de Andrade I; Matson DR; Dewey CN; Bresnick EH
    Nucleic Acids Res; 2021 Sep; 49(16):9007-9025. PubMed ID: 34059908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major 3'-5' Exoribonucleases in the Metabolism of Coding and Non-coding RNA.
    Dos Santos RF; Quendera AP; Boavida S; Seixas AF; Arraiano CM; Andrade JM
    Prog Mol Biol Transl Sci; 2018; 159():101-155. PubMed ID: 30340785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating the RNA processing and decay by the exosome: altering Rrp44/Dis3 activity and end-product.
    Reis FP; Barbas A; Klauer-King AA; Tsanova B; Schaeffer D; López-Viñas E; Gómez-Puertas P; van Hoof A; Arraiano CM
    PLoS One; 2013; 8(11):e76504. PubMed ID: 24265673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of the RNase II family of exoribonucleases from the human pathogens Salmonella typhimurium and Streptococcus pneumoniae.
    Domingues S; Matos RG; Reis FP; Fialho AM; Barbas A; Arraiano CM
    Biochemistry; 2009 Dec; 48(50):11848-57. PubMed ID: 19863111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing ribonucleases in vitro examples of synergies between biochemical and structural analysis.
    Arraiano CM; Barbas A; Amblar M
    Methods Enzymol; 2008; 447():131-60. PubMed ID: 19161842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RNA exosome affects iron response and sensitivity to oxidative stress.
    Tsanova B; Spatrick P; Jacobson A; van Hoof A
    RNA; 2014 Jul; 20(7):1057-67. PubMed ID: 24860016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exonuclease hDIS3L2 specifies an exosome-independent 3'-5' degradation pathway of human cytoplasmic mRNA.
    Lubas M; Damgaard CK; Tomecki R; Cysewski D; Jensen TH; Dziembowski A
    EMBO J; 2013 Jul; 32(13):1855-68. PubMed ID: 23756462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.